Jiang Wenbin 13D and 13G filings for Cytek Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:07 pm Sale |
2023-12-31 | 13G | Cytek Biosciences, Inc. CTKB |
Jiang Wenbin | 5,702,130 4.300% |
-2,318,353 (-28.91%) |
Filing |
| 2022-02-14 2:04 pm Purchase |
2021-12-31 | 13G | Cytek Biosciences, Inc. CTKB |
Jiang Wenbin | 8,020,483 5.990% |
8,020,483 (New Position) |
Filing |